Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection

International Immunology

Volumn 11, Issue 7, 1999, Pages 1043-1051

  Ben Yedidia, Tamar ^a   Marcus, Hadar ^a   Reisner, Yair ^a   Arnon, Ruth ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Epitope; Flagellin; Human; Influenza; Vaccine

Indexed keywords

INFLUENZA VACCINE; RECOMBINANT VACCINE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS; INTRANASAL DRUG ADMINISTRATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RADIATION CHIMERA; VACCINATION;

ADMINISTRATION, INTRANASAL; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID; MOLECULAR SEQUENCE DATA; RADIATION CHIMERA; VACCINES, INACTIVATED;

EID: 0032813525     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.7.1043     Document Type: Article

References (54)

1. Laver, W. G., Air, G. M., Dopheide, T. A. and Ward, C. W. 1980. Amino acids sequence changes in the Hemagglutinin of A/ Hong kong (H3N2) influenza virus during the period 1968-77. Nature 283:454.
2. Laver, W. G., Air, G. M., Webster, R. G., Gerhard, W., Ward, C. and Dopheid, T. 1980. Antigenic drift in type A influenza virus: sequence differences in the Hemagglutinin of Hong-Kong (H3N2) variants selected with monoclonal hybridoma antibody. Virology 98:226.
3. Webster, R. G., Laver, W. G., Air, G. M. and Schild, G. C. 1982. Molecular mechanism of variation in influenza viruses. Nature 296:115.
4. Arnon, A. and Levi, R. 1995. Synthetic recombinant vaccines against viral agents. Int. Arch. Allergy Immunol. 108:321.
5. Arnon, R. and Levi, R. 1996. Synthetic recombinant vaccine induces anti-influenza long-term immunity and cross strain protection. In Cohen, S. and Shafferman, A., eds, Novel Strategies in Design and Production of Vaccines, p. 23. Plenum Press, New York.
6. Shapira, M., Jibson, M., Muller, G. M. and Arnon, R. 1984. Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of the hemagglutinin. Proc. Natl Acad. Sci. USA 81:2461.
7. Rothbard, J. B., Pemberton, R. M., Bodmer, H. C., Askonas, B. A. and Taylor, W. R. 1989. Identification of residues necessary for clonally specific recognition of a cytotoxic T cell determinant. EMBO J. 8:2321.
8. Levi, R. and Arnon, R. 1996. Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection. Vaccine 14:85.
9. Reisner, Y. and Dagan, S. 1998. The trimera mouse: generating human monoclonal antibodies and an animal model for human diseases. Trends Biotechnol. 16:242.
10. Lubin, I., Segall, H., Marcus, H., David, M., Kulova, L., Steinitz, M., Erlich, P., Gan, J. and Reisner, Y. 1994. Engraftment of human peripheral blood lymphocytes in normal strains of mice. Blood 83:2368.
11. Posch, P. E., Araujo, H. A., Creswell, K., Praud, C., Johnson, A. H. and Hurley, C. K. 1995. Microvariation creates significant functional differences in the DR3 molecules. Hum. Immunol. 42:61.
12. Sutton, J., Rowland, J. S., Rosenberg, W., Nixon, D., Gotch, F., Gao, X. M., Murray, N., Spoonas, A., Driscoll, P., Smith, M., et al. 1993. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. Eur. J. Immunol. 23:447.
13. Van Schooten, W. C., Maiore, T., Jones, K. R. and Paborsky, L. 1992. Purified HLA class II peptide complexes can induce adherence and activation of peptide-specific human T cell clones. J. Immunol. 148:1043.
14. Sette, A., Sidney, J., Oseroff, C., del, G. M., Southwood, S., Arrhenius, T., Powell, M. F., Colon, S. M., Gaeta, F. C. and Grey, H. M. 1993. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 151:3163.
15. McMichael, A. J., Gotch, F. M. and Rothbard, J. 1986. HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes. J. Exp. Med. 164:1397.
16. Carreno, B. M., Anderson, R. W., Coligan, J. E. and Biddison, W. E. 1990. HLA-B37 and HLA-A2. 1 molecules bind largely nonoverlapping sets of peptides. Proc. Natl Acad. Sci. USA. 87:3420.
17. Carreno, B. M., Koenig, S., Coligan, J. E. and Biddison, W. E. 1992. The peptide binding specificity of HLA class I molecules is largely allele-specific and non-overlapping. Mol. Immunol. 29:1131.
18. Shapira, M., Jolivet, M. and Arnon, R. 1985. Synthetic vaccine against influenza with build-in adjuvanticity. Int. J. Immunopharmacol. 7:719.
19. Benjamin, R. J., Madrigal, J. A. and Parham, P. 1991. Peptide binding to empty HLA-B27 molecules of viable human cells. Nature 351:74.
20. + class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide. J. Immunol. 148:894.
21. Suhrbier, A., Schmidt, C. and Fernan, A. 1993. Prediction of an HLA B8-restricted influenza epitope by motif. Immunology 79:171.
22. O'Sullivan, D., Arrhenius, T., Sidney, J., Del, G. M., Albertson, M., Wall, M., Oseroff, C., Southwood, S., Colon, S. M., Gaeta, F. C., et al. 1991. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J. Immunol. 147:2663.
23. Rothbard, J. B., Busch, R., Bal, V., Trowsdale, J., Lechler, R. I. and Lamb, J. R. 1989. Reversal of HLA restriction by a point mutation in an antigenic peptide. Int. Immunol. 1:487.
24. Ikeda, K. and Katagiri, M. 1993. [Analysis of binding capacities between HLA class II molecules and synthetic peptides HA307-319]. Hokkaido Igaku Zasshi 68:318.
25. Levite, M., Meshorer, A. and Reisner, Y. 1991. A rapid method for obtaining murine bone marrow cells in high yield. Bone Marrow Transplant. 8:1.
26. Barrett, T. and Inglis, S. C. 1985. Growth purification and titration influenza viruses. In Mahy, W. J., ed. Virology: A Practical Approach, p. 119. IRL Press, Washington, DC.
27. Thompson, W. R. 1947. Use of moving averages and interpolation to estimate median-effective dose. Bacteriol. Rev. 11:115.
28. Marcus, H., David, M., Canaan, A., Kulova, L., Lubin, I., Segal, H., Denis, L., Erlich, P., Galun, E., Gan, J., Laster, M. and Reisner, Y. 1995. Human/mouse radiation chimera are capable of mounting a human primary humoral response. Blood 86:398.
29. Arnon, R. and Horwitz, R. J. 1992. Synthetic peptides as vaccines. Curr. Opin. Immunol. 4:449.
30. Dyer, P. and Middleton, D. 1993. In Rickwood, D. and Hames, B. D., eds, Histocompatibility Testing, A Practical Approach, p. 292. IRL Press, Oxford.
31. Gulukota, K. and DeLisi, C. 1996. HLA allele selection for designing peptide vaccines. Genet. Anal. Biomol. Eng. 13:81.
32. Mosier, D. E. 1991. Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS. Adv. Immunol. 50:303.
33. Sandhu, J., Shpitz, B., Gallinger, S. and Hozumi, N. 1994. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J. Immunol. 152:3806.
34. Nonoyama, S., Smith, F. and Ochs, H. 1993. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes. J. Immunol. 151:3894.
35. Abedi, M. R., Christensson, B., Islam, K. B., Hammarstrom, L. and Smith, C. I. 1992. Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. Eur. J. Immunol. 22:823.
36. Lue, C., Kiyono, H., Fujihashi, K., McGhee, J. R. and Mestecky, J. 1992. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens. Reg. Immunol. 4:86.
37. Carlsson, R., Martensson, C., Kalliomaki, S., Ohlin, M. and Borrebaeck, C. A. 1992. Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies. J. Immunol. 148:1065.
38. Duchosal, M. A., Eming, S. A., Fischer, P., Leturcq, D., Barbas, C. F., III, McConahey, P. J., Caothien, R. H., Thornton, G. B., Dixon, F. J. and Burton, D. R. 1992. Immunization of hu-PBL-SCID mice combinatorial libraries. Nature 355:258.
39. Leader, K. A., Macht, L. M., Steers, F., Kumpel, B. M. and Elson, C. J. 1992. Antibody responses to the blood group antigen D in SCID mice reconstituted with human blood mononuclear cells. Immunology 76:229.
40. Lucas, A. H., Siff, T. E., Trujillo, K. H. and Kitamura, M. Y. 1992. Vaccine-induced human antibody responses to the Haemophilus influenzae b polysaccharide in severe combined immunodeficient mice engrafted with human leukocytes. Pediatr. Res. 2:132.
41. Markham, R. B. and Donnenberg, A. D. 1992. Effect of donor and recipient immunization protocols on primary and secondary human antibody responses in SCID mice reconstituted with human peripheral blood mononuclear cells. Infect. Immun. 60:2305.
42. Mosier, D. E., Gulizia, R. J., MacIsaac, P. D., Corey, L. and Greenberg, P. D. 1993. Resistance to human immunodeficiency virus-1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc. Natl Acad. Sci. USA 90:2443.
43. Wu, S. J., Hayes, C. G., Dubois, D. R., Windheuser, M. G., Kang, Y. H., Watts, D. M. and Sieckmann, D. G. 1995. Evaluation of the severe combined immunodeficient (SCID) mouse as an anomal model for dengue viral infection. Am J. Trop. Med. Hyg. 52:468.
44. Boyle, M. J., Connors, M., Flanigan, M. E., Geiger, S. P., Ford Jr, H., Baseler, M., Adelsberger, J., Davey, R. T., Jr and Lane, C. 1995. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse: a modified human PBL-SCID model for the study of HIV pathogenesis and therapy. J. Immunol. 154:6612.
45. Segall, H., Lubin, I., Marcus, H., Canaan, A. and Reisner, Y. 1996. Generation of primary antigen-specific human cytotoxic T lymphocytes in human/mouse radiation chimera. Blood 88:721.
46. Burakova, T., Marcus, H., Canaan, A., Dekel, B., Shezen, E., David, M., Lubin, I., Segal, H. and Reisner, Y. 1997. Engrafted human T and B lymphocytes form mixed follicles in lymphoid organs of human/mouse and human/rat radiation chimera. Transplantation 63:1166.
47. Lubin, I. 1992. PhD dissertation. Weizmann Institute of Science, Rehovot, Israel.
48. Tary-Lehman, M. and Saxon, A. 1992. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J. Exp. Med. 175:503.
49. Albert, M. L., Sauter, B. and Bhardwaj, N. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86.
50. + T cells promote the clearance of influenza virus from major histocompatibility complex class II-/-respiratory epithelium. J. Virol. 70:1288.
51. Hayden, F. G., Fritz, R., Lobo, M. C., Alvord, W., Strober, W. and Straus, S. E. 1998. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 101:643.
52. Baumgarth, N. and Kelso, A. 1996. In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J. Virol. 70:4411.
53. Kurokawa, M., Imakita, M., Kumeda, C. A. and Shiraki, K. 1996. Cascade of fever production in mice infected with influenza virus. J. Med. Virol. 50:152.
54. Bocher, W. O., Marcus, H., Shakarchy, R., Dekel, B., Shouval, D., Galun, E. and Reisner, Y. 1999. Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo. Immunology 96: in press.